This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data
among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation,
prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.